Which has the lower trailing P/E, BSX or EW?

BSX has the lower trailing P/E: BSX trades at 17.32 and EW at 48.94. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BSX or EW?

Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus EW at 5.75%.

Is BSX or EW more profitable?

BSX runs the higher net margin — BSX at 17.47% versus EW at 15.43%.

How have BSX and EW total returns compared?

Over the past 10 years, BSX delivered 5.99% and EW delivered 7.79% annualized total return. Past performance doesn't predict future results.

Boston Scientific Corporation (BSX) vs Edwards Lifesciences Corporation (EW)

A side-by-side comparison of Boston Scientific Corporation and Edwards Lifesciences Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

BSX

Boston Scientific Corporation

$63.32B

$42.60HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Edwards Lifesciences Corporation

$49.03B

$85.15HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — BSX vs EW

growth of $100 · dividends reinvested · last 10y

BSX +79.4% (+6.0%/yr)EW +112.9% (+7.8%/yr)EW compounded faster over this window

BSX EW

BSX vs EW: by the numbers

•BSX is the larger company ($63.32B vs $49.03B market cap).
•BSX trades at the lower trailing earnings multiple (17.32 vs 48.94 P/E), one valuation lens rather than an overall verdict.
•BSX converts more revenue to profit (17.47% vs 15.43% net margin).
•BSX grew revenue faster over the past five years (13.40% vs 5.75% CAGR).

Metrics side by side

Valuation

Metric	BSX	EW
P/E ratio	17.32	48.94
Forward P/E	13.03	28.37
PEG ratio	0.58	6.91
P/S ratio	3.02	7.53
P/B ratio	2.54	4.62
EV / EBITDA	13.01	23.47
FCF yield	5.72%	2.92%

Profitability

Metric	BSX	EW
Gross margin	71.16%	77.98%
Operating margin	21.46%	28.09%
Net margin	17.47%	15.43%
ROE	14.71%	9.46%
ROIC	10.57%	10.22%

Growth (annualized)

Metric	BSX	EW
Revenue CAGR (5Y)	13.40%	5.75%
EPS CAGR (5Y)	29.71%	6.87%
FCF CAGR (5Y)	15.64%	6.41%
Total return CAGR (5Y)	0.09%	-5.38%

Frequently asked

Which has the lower trailing P/E, BSX or EW?: BSX has the lower trailing P/E: BSX trades at 17.32 and EW at 48.94. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BSX or EW?: Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus EW at 5.75%.
Is BSX or EW more profitable?: BSX runs the higher net margin — BSX at 17.47% versus EW at 15.43%.
How have BSX and EW total returns compared?: Over the past 10 years, BSX delivered 5.99% and EW delivered 7.79% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BSX analysis Full EW analysis Interactive comparison tool

Dig into the metrics

Boston Scientific P/E ratio Edwards Lifesciences P/E ratio Boston Scientific ROE Edwards Lifesciences ROE Boston Scientific operating margin Edwards Lifesciences operating margin Boston Scientific revenue growth Edwards Lifesciences revenue growth Boston Scientific free cash flow Edwards Lifesciences free cash flow

Boston Scientific & Edwards Lifesciences appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.